Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study.

    Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

    Diabetes Care. 2002 Dec;25(12):2320-7.PMID: 12453980 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus.

    Flores L, Vidal M, Abian J, Cases A, Campistol JM, Clària J, Lario S, Esmatjes E.

    Diabet Med. 2004 Mar;21(3):285-9.PMID: 15008841 [PubMed - indexed for MEDLINE]Related articles

    3.

    Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.

    Korpinen E, Teppo AM, Hukkanen L, Akerblom HK, Grönhagen-Riska C, Vaarala O.

    Diabetes Care. 2000 May;23(5):664-8.PMID: 10834427 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.

    Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O.

    Diabet Med. 2001 Feb;18(2):121-5.PMID: 11251675 [PubMed - indexed for MEDLINE]Related articles

    5.

    Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

    Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

    Diabetes Care. 2002 Jun;25(6):1072-7.PMID: 12032117 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.

    Flores L, Näf S, Hernáez R, Conget I, Gomis R, Esmatjes E.

    Diabet Med. 2004 Aug;21(8):818-22.PMID: 15270783 [PubMed - indexed for MEDLINE]Related articles

    7.

    Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

    Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW.

    Diabetes. 1999 Dec;48(12):2446-53.PMID: 10580435 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.

    Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD; EURODIAB Prospective Complications Study Group.

    Hypertension. 2005 Jul;46(1):232-7. Epub 2005 Apr 25.PMID: 15851628 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Urinary transforming growth factor-beta 1 in various types of nephropathy.

    De Muro P, Faedda R, Fresu P, Masala A, Cigni A, Concas G, Mela MG, Satta A, Carcassi A, Sanna GM, Cherchi GM.

    Pharmacol Res. 2004 Mar;49(3):293-8.PMID: 14726227 [PubMed - indexed for MEDLINE]Related articles

    11.

    Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

    Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N.

    Diabetologia. 2004 Jun;47(6):1020-8. Epub 2004 May 29.PMID: 15170497 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum transforming growth factor-beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone.

    Yener S, Comlekci A, Akinci B, Akan P, Demir T, Bayraktar F, Yesil S.

    Hormones (Athens). 2008 Jan-Mar;7(1):70-6.PMID: 18359746 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Activation of transforming growth factor-beta1 in diabetic kidney disease.

    Hellmich B, Schellner M, Schatz H, Pfeiffer A.

    Metabolism. 2000 Mar;49(3):353-9.PMID: 10726914 [PubMed - indexed for MEDLINE]Related articles

    14.

    Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.

    Diabetes Care. 2005 Nov;28(11):2716-21.PMID: 16249545 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.

    Esmatjes E, Flores L, Iñigo P, Lario S, Ruilope LM, Campistol JM.

    Nephrol Dial Transplant. 2001;16 Suppl 1:90-3.PMID: 11369831 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.
    18.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.

    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.

    Auton Neurosci. 2003 Mar 28;104(2):88-94.PMID: 12648610 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

    Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

    Kidney Int. 2005 Oct;68(4):1554-61.PMID: 16164632 [PubMed - indexed for MEDLINE]Related articles